Safety Profile of Etifoxine: A French Pharmacovigilance Survey

//Safety Profile of Etifoxine: A French Pharmacovigilance Survey

Safety Profile of Etifoxine: A French Pharmacovigilance Survey

Adverse drug reactions (ADRs) from over 14 million prescriptions of (StresamĀ®) etifoxine were reviewed and analyzed by the French National Agency for the Safety of Medicines and Health Products, between 2000 and 2012. The average incidence of ADRs was 0.0021% (21 per million treatments) and no cases of abuse, misuse or pharmacodependance were reported.

2019-04-13T21:50:35+00:00